CIK 0001796280 · Non-accelerated filer
Oric Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ORIC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471787157
- Phone
- (650) 388-5600
- Business address
- 240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,519,090
- in 5 filings, $1.5M under 10b5-1 plans
Net −$1,519,090. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-10 | Piscitelli Dominic Chief Financial Officer | Sale 10b5-1 | −324 | $10.00 | $3K | 105,093 |
| 2025-06-09 | Piscitelli Dominic Chief Financial Officer | Sale 10b5-1 | −300 | $10.00 | $3K | 103,864 |
| 2025-06-06 | Piscitelli Dominic Chief Financial Officer | Sale 10b5-1 | −2,600 | $10.01 | $26K | 104,164 |
| 2025-03-03 | Kunkel Lori Anne Director | Option exercise | +27,666 | $3.75 | $104K | 48,166 |
| 2025-03-03 | Kunkel Lori Anne Director | Option exercise | +20,500 | $6.33 | $130K | 68,666 |
| 2025-03-03 | Kunkel Lori Anne Director | Option exercise · Stock Option (right to buy) | −27,666 | 5,534 | ||
| 2025-03-03 | Kunkel Lori Anne Director | Option exercise · Stock Option (right to buy) | −20,500 | 0 | ||
| 2025-01-02 | You Angie Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2025-01-02 | Kunkel Lori Anne Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2025-01-02 | Hoerter Steven L. Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2025-01-02 | Heyman Richard A. Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2025-01-02 | Dier Mardi Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2025-01-02 | Multani Pratik S Chief Medical Officer | Grant or award · Stock Option (right to buy) | +202,500 | 202,500 | ||
| 2025-01-02 | Multani Pratik S Chief Medical Officer | Grant or award · Restricted Stock Unit | +34,000 | 34,000 | ||
| 2025-01-02 | Piscitelli Dominic Chief Financial Officer | Grant or award · Stock Option (right to buy) | +202,500 | 202,500 | ||
| 2025-01-02 | Piscitelli Dominic Chief Financial Officer | Grant or award · Restricted Stock Unit | +34,000 | 34,000 | ||
| 2025-01-02 | Chacko Jacob PRESIDENT AND CEO | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2025-01-02 | Chacko Jacob PRESIDENT AND CEO | Grant or award · Restricted Stock Unit | +100,000 | 100,000 | ||
| 2024-12-16 | Piscitelli Dominic Chief Financial Officer | Sale | −8,851 | $8.28 | $73K | 106,764 |
| 2024-12-16 | Multani Pratik S Chief Medical Officer | Sale | −8,850 | $8.28 | $73K | 46,765 |
Page 5 of 12 · 228 trades